The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2020

Filed:

Mar. 28, 2014
Applicant:

Sumitomo Dainippon Pharma Co., Ltd., Osaka-shi, JP;

Inventors:

Hitoshi Ban, Osaka, JP;

Yukihiro Nishio, Osaka, JP;

Masashi Goto, Osaka, JP;

Yosuke Takanashi, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/12 (2006.01); A61K 39/00 (2006.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 47/646 (2017.08); C12N 9/12 (2013.01); A61K 2039/572 (2013.01); A61K 2039/627 (2013.01); C12Y 207/10001 (2013.01);
Abstract

The present invention provides a compound represented by the formula (1): wherein Xand Yare each a single bond or the like, cancer antigen peptide A is an MHC class I-restricted cancer antigen peptide, andRis a hydrogen atom; a group represented by the formula (2): wherein Xand Yare each a single bond or the like, and cancer antigen peptide B is different from the cancer antigen peptide A and is an MHC class I or II-restricted cancer antigen peptide; a group represented by the formula (3): wherein Xand Yare each a single bond or the like, and cancer antigen peptide C is an MHC class II-restricted cancer antigen peptide; or cancer antigen peptide D, wherein the cancer antigen peptide D is an MHC class I or II-restricted cancer antigen peptide containing one cysteine residue,or a salt thereof, for example.


Find Patent Forward Citations

Loading…